| 2002D-0389 | Nonclinical Studies for Development of Pharmaceutical Excipi | |||||||||||||||||||||||
| FDA Comment Number : | EC1 | |||||||||||||||||||||||
| Submitter : | Ms. Mary G. Harrison | Date & Time: | 09/09/2005 05:09:49 | |||||||||||||||||||||
| Organization : | NOW | |||||||||||||||||||||||
| Category : | Other Organization | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| Abortion and birth control devices and medication must be abailable to women/girls without interference of church or state. Men should not be allowed to interfere in women's decisions regarding their own bodies. Clinical studies should be directed toward women's needs, with closely supervised studies which ensure women's needs are addressed. | ||||||||||||||||||||||||